ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #5,488Hybrid

Molecular Medicine Reports

Abbreviation (ISO):MOL. MED. REP
•
Identifier (ISSN):1791-2997(Print)/1791-3004(Online)
•
Publisher:Spandidos Publications
Clarivate IF (2026)
5↑ +1.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Molecular Medicine Reports

WoS Q2
13572.120202.9520213.4220223.420233.420243.5202552026
Annual Impact Factor Metric
Current (2026):5
Scopus SJR & RankScopus Q2
0.933
#5,488

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
106

106 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
806articles/year
93.42% Gold OA•89.06% Original Research

Aims & Scope

Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.

Topics Covered (Recognized by AI)
Biology99.7%Medicine96.8%Genetics96.6%Chemistry96.6%Biochemistry95.6%Internal medicine90.7%Gene75.5%Apoptosis62.9%Cell53.7%Cell biology51.2%Cancer51%Cancer research48.2%Cell cycle45.6%Immunology40.6%Endocrinology39.9%Pathology39.5%Oncogene34.8%Cell culture29.4%Molecular biology28.7%In vitro26.7%Organic chemistry26.7%Physics24.4%Signal transduction24%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank49/191
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q2
Rank86/333
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank59/191
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank108/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5
Articles / Year238
Total Citations990
2025
IF3.5
Articles / Year359
Total Citations1,204
2024
IF3.4
Articles / Year273
Total Citations2,495
2023
IF3.4
Articles / Year230
Total Citations2,193
2022
IF3.423
Articles / Year344
Total Citations4,612

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,488Scopus Q2SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q2
0.933

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
4.04

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,183 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,228
3-Year Documents807
Citable Documents807

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ2
Cancer ResearchQ2
GeneticsQ2
Molecular BiologyQ2
Molecular MedicineQ2
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
In warning list
2021
In warning list
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Medicine Reports (abbr: MOL. MED. REP, ISSN: 1791-2997) is a peer-reviewed international scholarly journal in the field of Medicine, published by Spandidos Publications in Greece since 2008. The periodical holds a Journal Impact Factor (JIF) of 5.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.933 (Q2), an H-index of 106.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 806 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,183 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Spandidos Publications
Publication Language
English
Frequency
Bimonthly
Founding Year
2008
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPANDIDOS PUBL LTD, POB 18179, ATHENS, GREECE, 116 10

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cf8da8c9-1ae3-4f57-9748-18734b81af3c
Database Updated: 2026-10-01